Search

everythinglearnresearchcommunity

for

Search:↓

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Women with different PCOS types have similar fertility treatment results.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Trichoscopy is a useful non-invasive method for diagnosing different hair loss conditions.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.